Translation of acute coronary syndrome therapies: From evidence to routine clinical practice

American Heart Journal

Volumn 169, Issue 2, 2015, Pages 266-273

  Putera, Martin ^a   Roark, Robin ^b   Lopes, Renato D ^c   Udayakumar, Krishna ^a,b   Peterson, Eric D ^b,c   Califf, Robert M ^b   Shah, Bimal R ^b,c  

^a Singapore Graduate Medical School   (Singapore)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENOXAPARIN; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; FONDAPARINUX; HEPARIN; HIRULOG; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRASUGREL; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR; CARDIOVASCULAR AGENT;

ACUTE CORONARY SYNDROME; ARTICLE; CLINICAL PRACTICE; DISEASE REGISTRY; EVIDENCE BASED PRACTICE; HEART INFARCTION; HUMAN; MEDICAL SOCIETY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PEER REVIEW; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; UNSTABLE ANGINA PECTORIS; ANGINA, UNSTABLE; CLASSIFICATION; COMMUNICATION DISORDER; EARLY INTERVENTION; MEANINGFUL USE CRITERIA; MYOCARDIAL INFARCTION; NEEDS ASSESSMENT; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGISTER; STANDARDS; STATISTICS AND NUMERICAL DATA; TRANSLATIONAL RESEARCH;

ANGINA, UNSTABLE; CARDIOVASCULAR AGENTS; COMMUNICATION BARRIERS; EARLY MEDICAL INTERVENTION; EVIDENCE-BASED PRACTICE; GUIDELINE ADHERENCE; HUMANS; MEANINGFUL USE; MYOCARDIAL INFARCTION; NEEDS ASSESSMENT; PRACTICE GUIDELINES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGISTRIES; RISK ASSESSMENT; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84921745472     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2014.09.015     Document Type: Article

References (39)

1. E.D. Peterson, B.R. Shah, and L. Parsons Trends in quality of care for patients with acute myocardial infarction in the National Registry of Myocardial Infarction from 1990 to 2006 Am Heart J 156 2008 1045 1055
2. E.M. Antman, D.T. Anbe, and P.W. Armstrong ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction) Circulation 110 2004 e82 e292
3. E.M. Antman, M. Hand, and P.W. Armstrong 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee Circulation 117 2008 296 329
4. F.G. Kushner, M. Hand, and S.C. Smith Jr. 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (updating the 2005 Guideline and 2007 Focused Update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 120 2009 2271 2306
5. J.L. Anderson, C.D. Adams, and E.M. Antman ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine Circulation 116 2007 e148 e304
6. R.S. Wright, J.L. Anderson, and C.D. Adams 2011 ACCF/AHA focused update of the Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction (updating the 2007 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American College of Emergency Physicians, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons J Am Coll Cardiol 57 2011 1920 1959
7. R.M. Gunnar, P.D. Bourdillon, and D.W. Dixon ACC/AHA guidelines for the early management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (subcommittee to develop guidelines for the early management of patients with acute myocardial infarction) Circulation 82 1990 664 707
8. T.J. Ryan, J.L. Anderson, and E.M. Antman ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction) J Am Coll Cardiol 28 1996 1328 1428
9. T.J. Ryan, E.M. Antman, and N.H. Brooks 1999 update: ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction: Executive Summary and Recommendations: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction) Circulation 100 1999 1016 1030
10. E. Braunwald, E.M. Antman, and J.W. Beasley ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on the management of patients with unstable angina) Circulation 102 2000 1193 1209
11. E. Braunwald, E.M. Antman, and J.W. Beasley ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina) Circulation 106 2002 1893 1900
12. E.M. Ohman, M.T. Roe, and S.C. Smith Jr. Care of non-ST-segment elevation patients: insights from the CRUSADE national quality improvement initiative Am Heart J 148 2004 S34 S39
13. E.D. Peterson, M.T. Roe, and J.S. Rumsfeld A call to ACTION (acute coronary treatment and intervention outcomes network): a national effort to promote timely clinical feedback and support continuous quality improvement for acute myocardial infarction Circ Cardiovasc Qual Outcomes 2 2009 491 499
14. E.D. Peterson, M.T. Roe, and A.Y. Chen The NCDR ACTION Registry-GWTG: transforming contemporary acute myocardial infarction clinical care Heart 96 2010 1798 1802
15. R.H. Mehta, M.T. Roe, and A.Y. Chen Recent trends in the care of patients with non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE initiative Arch Intern Med 166 2006 2027 2034
16. M.D. Cabana, C.S. Rand, and N.R. Powe Why don't physicians follow clinical practice guidelines? A framework for improvement JAMA 282 1999 1458 1465
17. R. Nieuwlaat, J.D. Schwalm, and R. Khatib Why are we failing to implement effective therapies in cardiovascular disease? Eur Heart J 34 2013 1262 1269
18. J.M. Grimshaw, R.E. Thomas, and G. MacLennan Effectiveness and efficiency of guideline dissemination and implementation strategies Health Technol Assess 8 2004 iii iv [1-72]
19. L. Olsen, D. Aisner, and J.M. McGinnis The Learning Healthcare System: Workshop Summary Institute of Medicine (US) Roundtable on Evidence-Based Medicine 2007 National Academies Press (US) Washington, DC
20. M.S. Sabatine, C.P. Cannon, and C.M. Gibson Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation N Engl J Med 352 2005 1179 1189
21. S.R. Mehta, S. Yusuf, and R.J. Peters Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study Lancet 358 2001 527 533
22. S.R. Steinhubl, P.B. Berger, and J.T. Mann III Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention JAMA 288 2002 2411 2420
23. No authors listed Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet 344 1994 1383 1389
24. F.M. Sacks, M.A. Pfeffer, and L.A. Moyé The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators N Engl J Med 335 1996 1001 1009
25. Heart Protection Study Collaborative Group MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial Lancet 360 2002 7 22
26. J.A. de Lemos, M.A. Blazing, and S.D. Wiviott Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial JAMA 292 2004 1307 1316
27. No authors listed Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group Lancet 2 1986 57 66
28. No authors listed GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico Lancet 343 1994 1115 1122
29. K. Dickstein, and J. Kjekshus Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan Lancet 360 2002 752 760
30. M.A. Pfeffer, K. Swedberg, and C.B. Granger Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme Lancet 362 2003 759 766
31. B. Pitt, W. Remme, and F. Zannad Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction N Engl J Med 348 2003 1309 1321
32. No authors listed Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group Lancet 2 1988 349 360
33. S. Yusuf, F. Zhao, and S.R. Mehta Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 2001 494 502
34. No authors listed Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study Lancet 349 1997 1429 1435
35. T.C. Chalmers, R.J. Matta, and H. Smith Jr. Evidence favoring the use of anticoagulants in the hospital phase of acute myocardial infarction N Engl J Med 297 1977 1091 1096
36. E.M. Antman, D.A. Morrow, and C.H. McCabe Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction N Engl J Med 354 2006 1477 1488
37. M. Cohen, C. Demers, and E.P. Gurfinkel A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group N Engl J Med 337 1997 447 452
38. R.G. Wilcox, G. von der Lippe, and C.G. Olsson Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET) Lancet 2 1988 525 530
39. No authors listed Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI) Lancet 1 1986 397 402